What is the recommended dose of co-amoxiclav (amoxicillin-clavulanic acid) for a 10-month-old pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-amoxiclav Dosing for a 10-Month-Old Pediatric Patient

For a 10-month-old pediatric patient, the recommended dose of co-amoxiclav (amoxicillin-clavulanic acid) is 2.5 ml/kg of 125/31 suspension three times daily. 1

Dosing Guidelines Based on Age and Weight

  • For children under 1 year of age (including 10-month-olds), the appropriate dose is 2.5 ml/kg of 125/31 suspension three times daily 1
  • For infants less than 12 weeks (3 months), the upper limit of amoxicillin dosing is 30 mg/kg/day divided every 12 hours due to incompletely developed renal function 2
  • For children 3 months and older but weighing less than 40 kg, the FDA recommends dosing based on severity of infection 2:
    • For mild/moderate infections: 25 mg/kg/day of amoxicillin component divided every 12 hours or 20 mg/kg/day divided every 8 hours 2
    • For severe infections: 45 mg/kg/day of amoxicillin component divided every 12 hours or 40 mg/kg/day divided every 8 hours 2

Formulation Considerations

  • Co-amoxiclav is available as an oral suspension with different ratios of amoxicillin to clavulanic acid 3
  • The 125/31 suspension contains 125 mg amoxicillin and 31 mg clavulanic acid per 5 ml 1
  • The suspension should be shaken well before use and can be administered directly or mixed with formula, milk, fruit juice, or water 2
  • To minimize gastrointestinal intolerance, co-amoxiclav should be taken at the start of a meal 2, 3

Duration of Treatment

  • Treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic 2
  • For infections caused by Streptococcus pyogenes, a minimum of 10 days of treatment is recommended to prevent acute rheumatic fever 2
  • Children on adequate therapy should demonstrate clinical improvement within 48-72 hours 4

Special Considerations for Respiratory Infections

  • For respiratory tract infections, particularly those involving β-lactamase producing H. influenzae, amoxicillin-clavulanate at 45 mg/kg/day in 3 doses or 90 mg/kg/day in 2 doses may be recommended 5
  • In areas with high prevalence of penicillin-resistant Streptococcus pneumoniae, higher dosing may be warranted 5

Potential Adverse Effects

  • The most common adverse effects include gastrointestinal disturbances such as diarrhea, which is more common with amoxicillin-clavulanate than with some other antibiotics 1, 6
  • Rash, urticaria, and other hypersensitivity reactions may occur 1
  • Monitoring for signs of allergic reaction is important, especially with the first few doses 1
  • Diarrhea is generally less frequent with twice-daily than with three-times-daily treatment 6

Clinical Monitoring

  • Monitor for clinical improvement within 48-72 hours of starting therapy 4
  • If the child's condition deteriorates after starting therapy or shows no improvement within 48-72 hours, further investigation should be performed 4
  • Any unused portion of the reconstituted suspension must be discarded after 14 days 2

Practical Administration Tips

  • After reconstitution, the required amount of suspension can be placed directly on the child's tongue or mixed with formula, milk, or juice 2
  • These preparations should be taken immediately after mixing 2
  • Refrigeration of the reconstituted suspension is preferable but not required 2

References

Guideline

Amoxicillin-Clavulanate Dosing Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amoxicillin-Clavulanate Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.